Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Lincare Holdings, Inc (“Lincare” or the “Company”) (Nasdaq: LNCR) relating to the proposed acquisition by Linde AG. (“Linde”). Under the terms of the transaction, Lincare shareholders will receive only $41.50 in cash for each of Lincare stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Lincare for not acting in the Company’s shareholders' best interests in connection with the sale process to Linde. The Board of Directors may have failed to adequately shop the Company and may have undervalued Lincare resulting in harm to the Lincare shareholders. If you own shares of Lincare stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com visiting http://brodsky-smith.com/445-lncr-lincare-holdings-inc.html, or by calling toll free 877-LEGAL-90.